Table 1.
Characteristics of the 71 SARS patients included in the final analysis in 2003
| Characteristics | Categories | N (%) |
|---|---|---|
| General status | ||
| Age (n = 71) | ||
| <30 | 30 (42.25%) | |
| 30–39 | 28 (39.44%) | |
| 40–49 | 8 (11.27%) | |
| ≥50 | 5 (7.04%) | |
| Gender (n = 71) | ||
| Female | 56 (78.87%) | |
| Male | 15 (21.13%) | |
| Personal medical history (n = 58) | ||
| Hypertension | 4 (6.90%) | |
| Diabetes | 1 (1.72%) | |
| Sjogren’s syndrome | 1 (1.72%) | |
| Smoke | 3 (5.17%) | |
| Clinical symptoms | ||
| Fever (n = 56) | Yes | 56 (100%) |
| Rigor (n = 57) | Yes | 36 (63.16%) |
| Dyspnea (n = 57) | Yes | 35 (61.40%) |
| Myalgia (n = 56) | Yes | 37 (66.07%) |
| Cough (n = 57) | Yes | 29 (50.88%) |
| Expectoration (n = 56) | Yes | 10 (17.86%) |
| Diarrhea (n = 56) | Yes | 10 (17.86%) |
| Anorexia (n = 56) | Yes | 23 (41.07%) |
| Malaise (n = 56) | Yes | 42 (75.00%) |
| Treatment | ||
| Ribavirin (n = 52) | Used | 46 (88.46%) |
| MP (n = 58) | Used | 56 (96.55%) |
| Non-invasive ventilation (n = 45) | Used | 14 (31.11%) |
| Invasive ventilation (n = 58) | Used | 1 (1.72%) |
| Severity | ||
| Lung injury (n = 71) | Yes | 27 (38.03%) |
| Bone injury (n = 71) | Yes | 15 (21.13%) |